A股異動 | 英飛特(300582.SZ)大漲近13% 2020年淨利預增40%-60%
格隆匯1月25日丨英飛特(300582.SZ)大幅高開,現漲12.7%,報18.9元,總市值37.4億元。英飛特24日發佈業績預吿,預計2020年度歸母淨利1.49億元-1.7億元,同比增長40%-60%。報吿期內,公司在生產經營活動受疫情影響的情況下,積極調整經營策略,加強國內外市場拓展、新業務及重點客户的開發,釋放過往業務項目積累,LED驅動電源業務在疫情壓力下營業收入較去年同期仍有所增長。另外,公司新能源汽車充電設施相關業務市場拓展順利,營業收入較上年同期有較大增幅。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.